Dale C Hesdorffer1, Jamshid Ghajar. 1. Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA. dch5@columbia.edu
Abstract
BACKGROUND: Prior surveys of acute medical management of severe traumatic brain injury (TBI) indicate that care is fragmented and inconsistent, although Guidelines for the management of severe traumatic brain injury (guidelines) were distributed and endorsed by the American Association of Neurologic Surgeons. We conducted a survey of US trauma centers to evaluate guideline adherence, to examine predictors of adherence, and to compare our results with similar surveys conducted in 1991 and 2000. METHODS: A Web-based survey was conducted in 413 designated trauma centers admitting patients with severe TBI. Good adherence was defined as adherence to the median number of guidelines (median = 6, interquartile range 5-7). RESULTS: In adjusted analysis, good adherence was predicted by Level I trauma center designation and presence of treatment protocols. Compared with trauma centers without these predictive factors, the likelihood of good guideline adherence increased 2.4-fold with each additional predictor (95% confidence interval = 1.8-3.3). Routine intracranial pressure monitor use increased from 32.4% in 1991 and 50.8% in 2000 to 77.4% in the current survey (p < 0.0001). Avoidance of steroids in TBI rose from 47.8% in 1991 and 52.4% in 2000 to 86.0% in 2006 (p < 0.0001). Lack of guideline adherence decreased significantly from 67% in 2006 to 34.5%. CONCLUSIONS: Adherence to evidence-based guidelines for severe TBI has improved dramatically since 1991. Trauma center level and treatment protocols were associated with good adherence, suggesting that directing patients with severe TBI to Level I and Level II trauma centers with treatment protocols will improve outcome for these patients.
BACKGROUND: Prior surveys of acute medical management of severe traumatic brain injury (TBI) indicate that care is fragmented and inconsistent, although Guidelines for the management of severe traumatic brain injury (guidelines) were distributed and endorsed by the American Association of Neurologic Surgeons. We conducted a survey of US trauma centers to evaluate guideline adherence, to examine predictors of adherence, and to compare our results with similar surveys conducted in 1991 and 2000. METHODS: A Web-based survey was conducted in 413 designated trauma centers admitting patients with severe TBI. Good adherence was defined as adherence to the median number of guidelines (median = 6, interquartile range 5-7). RESULTS: In adjusted analysis, good adherence was predicted by Level I trauma center designation and presence of treatment protocols. Compared with trauma centers without these predictive factors, the likelihood of good guideline adherence increased 2.4-fold with each additional predictor (95% confidence interval = 1.8-3.3). Routine intracranial pressure monitor use increased from 32.4% in 1991 and 50.8% in 2000 to 77.4% in the current survey (p < 0.0001). Avoidance of steroids in TBI rose from 47.8% in 1991 and 52.4% in 2000 to 86.0% in 2006 (p < 0.0001). Lack of guideline adherence decreased significantly from 67% in 2006 to 34.5%. CONCLUSIONS: Adherence to evidence-based guidelines for severe TBI has improved dramatically since 1991. Trauma center level and treatment protocols were associated with good adherence, suggesting that directing patients with severe TBI to Level I and Level II trauma centers with treatment protocols will improve outcome for these patients.
Authors: Eduardo Paredes-Andrade; Craig A Solid; Sarah B Rockswold; Rick M Odland; Gaylan L Rockswold Journal: Neurocrit Care Date: 2012-10 Impact factor: 3.210
Authors: Randall M Chesnut; Nancy Temkin; Walter Videtta; Gustavo Petroni; Silvia Lujan; Jim Pridgeon; Sureyya Dikmen; Kelley Chaddock; Jason Barber; Joan Machamer; Nahuel Guadagnoli; Peter Hendrickson; Sergio Aguilera; Victor Alanis; Manuel Enrique Bello Quezada; Ermitaño Bautista Coronel; Luis Alberto Bustamante; Armando C Cacciatori; Carlos Javier Carricondo; Felipe Carvajal; Rafael Davila; Mario Dominguez; Jairo Antonio Figueroa Melgarejo; Maria Martha Fillipi; Daniel A Godoy; Delia Cristina Gomez; Angel J Lacerda Gallardo; Juan Antonio Guerra Garcia; Gustavo la Fuente Zerain; Luis Arturo Lavadenz Cuientas; Cecilio Lequipe; Gerardo Vicente Grajales Yuca; Manuel Jibaja Vega; Michael Eduardo Kessler; Hubiel J López Delgado; Freddy Sandi Lora; Ana Maria Mazzola; Roberto Merida Maldonado; Natascha Mezquia de Pedro; J Ricardo Martínez Zubieta; Julio C Mijangos Méndez; Jacobo Mora; Johnny Marcelo Ochoa Parra; Perla B Pahnke; Jorge Paranhos; Gustavo R Piñero; Francisco A Rivadeneira Pilacuán; Mario Napoleon Mendez Rivera; Ricardo Luis Romero Figueroa; Andres M Rubiano; Alexandra Matilde Saraguro Orozco; Juan Ignacio Silesky Jiménez; Luis Silva Naranjo; Caridad Soler Morejon; Zulma Urbina Journal: J Neurotrauma Date: 2020-03-04 Impact factor: 5.269
Authors: Patrick M Archambault; France Légaré; André Lavoie; Marie-Pierre Gagnon; Jean Lapointe; Sylvie St-Jacques; Julien Poitras; Karine Aubin; Sylvain Croteau; Martin Pham-Dinh Journal: Implement Sci Date: 2010-06-11 Impact factor: 7.327
Authors: Randall M Chesnut; Nancy Temkin; Sureyya Dikmen; Carlos Rondina; Walter Videtta; Gustavo Petroni; Silvia Lujan; Victor Alanis; Antonio Falcao; Gustavo de la Fuenta; Luis Gonzalez; Manuel Jibaja; Arturo Lavarden; Freddy Sandi; Roberto Mérida; Ricardo Romero; Jim Pridgeon; Jason Barber; Joan Machamer; Kelley Chaddock Journal: J Neurotrauma Date: 2017-09-26 Impact factor: 5.269
Authors: Monica S Vavilala; Mary A Kernic; Jin Wang; Nithya Kannan; Richard B Mink; Mark S Wainwright; Jonathan I Groner; Michael J Bell; Christopher C Giza; Douglas F Zatzick; Richard G Ellenbogen; Linda Ng Boyle; Pamela H Mitchell; Frederick P Rivara Journal: Crit Care Med Date: 2014-10 Impact factor: 7.598